Study of serum magnesium levels in hypertensive disorder and normal pregnancy and its correlation with feto-maternal outcome.
Not Applicable
- Conditions
- Health Condition 1: O14- Pre-eclampsia
- Registration Number
- CTRI/2024/03/064888
- Lead Sponsor
- AVBRH DMIHER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Pregnant women with clinically diagnosed preeclampsia with gestational age above 28 weeks.
2)Singleton pregnancy.
3)Those patients who are willing to get enrolled in the study.
Exclusion Criteria
1.Women with essential hypertension, chronic renal disease, liver disease, sickle cell anemia, diabetes mellitus, Rh isoimmunization, peptic ulcer disease, patients on magnesium containing antacids, retroviral disease patients were excluded.
2.In addition women with multiple gestation
dietary magnesium supplementation found in some prenatal multivitamin combinations.
3.Pregnant women who smoke cigarette or consume alcohol were also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method